Introduction
Therapeutic Drug Monitoring (TDM) is an evolving tool used to optimise the administration of antimicrobial agents; which are well documented to have toxic side effects [1] . In combination with increasing antimicrobial resistance and emphasis on cost-efficiency, provision of the optimal dose of antimicrobial therapy is a very attractive prospect.
Pharmacokinetic (PK) indices can be used to classify the efficacy of an antimicrobial agent. Critical illness may alter a patients PK behaviour [2] and therefore these patients may require alternative dosing regimens for optimal management [3] .
Objectives
The aim was to evaluate the current use of TDM in Intensive Care Units (ICU's) across London, focusing on the availability of results, the range of drugs for which TDM is offered and presence of critical care specific regimens.
Methods
A 6 part questionnaire was developed, and data collection was achieved by telephone interviews with Critical Care Pharmacists at 27 London Hospitals between February and April 2015.
Results
All hospitals offered TDM, however there were significant differences in the application of this tool. TDM was reported to be available for Gentamicin, 
Conclusions
This initial survey across London demonstrates that whilst commonly used antimicrobial agents are often used with TDM to guide therapy, there is still large variation in the range of antimicrobials for which TDM is available. There was also shown to be discrepancy in the availability of test results, which may impact on patient care if potentially toxic or sub-therapeutic levels take 
